IntegraGen | GenomeWeb

IntegraGen

The planned sequencing platform will be used for both exome and whole-genome sequencing research projects in the fields of cancer, rare diseases, microbiology, and potentially psychiatry.

The company will work with the investigators to examine whether levels of the microRNA can predict patient outcomes to different anti-EGRF therapies.

The hospital will use the new methods with jointly developed bioinformatic analysis techniques to rapidly interpret genomic data. 

IntegraGen will conduct sequencing for theNationalReferenceCenterand the microbiological collections at Institut Pasteur.

Genoma will commercialize the Arisk test outside the US and will provide genetic consulting services and diagnostics services to children with ASD and their parents.

The partners will try to validate the ability of has-miR-31-3p to predict which patients may benefit from anti-EGFR therapy.

The signatures involve a panel of genes that help researchers to distinguish between benign and malignant liver tumors and identify histological subtypes

NEW YORK (GenomeWeb) – Molecular diagnostics firm IntegraGen announced that it is collaborating with the French Intergroup of Thoracic Oncology (IFCT), a network of lung cancer specialists, to investigate the potential of a specific microRNA as a biomarker for advanced non-small cell lung cancer.

NEW YORK (GenomeWeb) – A French group spearheaded by genomics services provider IntegraGen said today that it would collaborate on a project to develop software to support data interpretation of next-generation sequencing of cancer patients.

NEW YORK (GenomeWeb) − In an effort to support clinical trials with cancer exome and transcriptome sequencing, cancer center Gustave Roussy and genomics firm IntegraGen, both of France, said l

Pages

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.